Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Steger

Showing results (171-180 of 320) with videos related to

Pageof 32
Sort By:
British Journal of Clinical Pharmacology|March 1, 1994
Pharmacokinetics of rac-leucovorin vs [S]-leucovorin in patients with advanced gastrointestinal cancerR M Mader, G G Steger, B Rizovski, et al.
Plos One|August 22, 2014
Indocyanine green video angiography predicts outcome of extravasation injuriesWerner Haslik, Ursula Pluschnig, Günther G Steger, et al.
Wiener Klinische Wochenschrift|May 29, 1987
[Reversible opening of the blood-brain barrier in the chemotherapy of malignant gliomas]K Heimberger, P Samec, I Podreka, et al.
Metabolism: Clinical and Experimental|February 1, 1992
Short-term energy balance in patients with infections: carbohydrate-based versus fat-based dietsB Schneeweiss, W Graninger, P Ferenci, et al.
Acta Radiologica. Supplementum|January 1, 1986
Blood brain barrier modification and chemotherapy. Interventional neuroradiology in the treatment of malignant gliomasK Heimberger, P Samec, H Binder, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
DNA ploidy and other results of DNA flow cytometry as prognostic factors in operable breast cancer: 10 year results of a randomised studyM F Gnant, G Blijham, A Reiner, et al.
Journal of Thrombosis and Haemostasis : JTH|November 6, 2009
High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)R Simanek, R Vormittag, C Ay, et al.
Onkologie|October 1, 1989
Vindesine-epirubicin versus vindesine-mitoxantrone in metastatic breast cancerH Hausmaninger, M Lehnert, G Steger, et al.
Anti-Cancer Drugs|March 27, 2002
Combined analysis of two phase II trials in patients with primary and advanced breast cancer with epidoxorubicin and docetaxel+granulocyte colony stimulating factorCatharina Wenzel, Gottfried J Locker, Manuela Schmidinger, et al.
Cancer Chemotherapy and Pharmacology|April 28, 2021
Tissue distribution of epirubicin after severe extravasation in humansJakob Nedomansky, Werner Haslik, Ursula Pluschnig, et al.
Pageof 32

Showing results (171-180 of 320) with videos related to

Sort By:
Pageof 32
British Journal of Clinical Pharmacology|March 1, 1994
Pharmacokinetics of rac-leucovorin vs [S]-leucovorin in patients with advanced gastrointestinal cancerR M Mader, G G Steger, B Rizovski, et al.
Plos One|August 22, 2014
Indocyanine green video angiography predicts outcome of extravasation injuriesWerner Haslik, Ursula Pluschnig, Günther G Steger, et al.
Wiener Klinische Wochenschrift|May 29, 1987
[Reversible opening of the blood-brain barrier in the chemotherapy of malignant gliomas]K Heimberger, P Samec, I Podreka, et al.
Metabolism: Clinical and Experimental|February 1, 1992
Short-term energy balance in patients with infections: carbohydrate-based versus fat-based dietsB Schneeweiss, W Graninger, P Ferenci, et al.
Acta Radiologica. Supplementum|January 1, 1986
Blood brain barrier modification and chemotherapy. Interventional neuroradiology in the treatment of malignant gliomasK Heimberger, P Samec, H Binder, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
DNA ploidy and other results of DNA flow cytometry as prognostic factors in operable breast cancer: 10 year results of a randomised studyM F Gnant, G Blijham, A Reiner, et al.
Journal of Thrombosis and Haemostasis : JTH|November 6, 2009
High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)R Simanek, R Vormittag, C Ay, et al.
Onkologie|October 1, 1989
Vindesine-epirubicin versus vindesine-mitoxantrone in metastatic breast cancerH Hausmaninger, M Lehnert, G Steger, et al.
Anti-Cancer Drugs|March 27, 2002
Combined analysis of two phase II trials in patients with primary and advanced breast cancer with epidoxorubicin and docetaxel+granulocyte colony stimulating factorCatharina Wenzel, Gottfried J Locker, Manuela Schmidinger, et al.
Cancer Chemotherapy and Pharmacology|April 28, 2021
Tissue distribution of epirubicin after severe extravasation in humansJakob Nedomansky, Werner Haslik, Ursula Pluschnig, et al.
Pageof 32